Drugs / Tremelilumab
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT03267589 | May 2018 → Oct 2021 | ovarian cancer | Nordic Society of Gynaecological Oncology - Clinical Trials Unit | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tremelilumab | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03267589 ↗ |